TP53 and cancer: To assess the efficacy of atomistic simulations for understanding the mutant-structure-function relationship of IDPs, we exploit the intrinsically disordered transactivation domain (TAD) of the tumor suppressor p53 and its cancer-associated mutations as a model system of great biological and biomedical significance.